Although wildtype IDH1 was frequently found in glioblastoma patients with unmethylated MGMT promoter, there was no significant relationship between IDH1 mutation and MGMT promoter methylation in the study group (p-value = 0.972) (Table 2). The gene discussed is IDH1; the disease is glioblastoma.